Cashlez Worldwide Indonesia Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Cashlez Worldwide Indonesia Tbk. trades at Rp202 (market cap 300.54B, 2.79M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Cashlez Worldwide Indonesia Tbk. and Diagnos Laboratorium Utama Tbk. are close in size by market cap, and Cashlez Worldwide Indonesia Tbk. is more actively traded (2.79M versus 963.6K). Which is the better fit depends on your goals.
| CASH | DGNS | |
|---|---|---|
Market Cap | 300.54B | 310.75B |
Volume | 2.79M | 963.6K |
Lot | 27.88K | 9.64K |
Turnover | 587.94M | 217.67M |
Average Price | 210.91 | 225.89 |
Value | 587.94M | 217.67M |
Indicative Equilibrium Price | 202 | 226 |
Indicative Equilibrium Volume | 652 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cashlez Worldwide Indonesia Tbk (the Company) was established based on Notarial DeedNo. 1 dated January 12, 2015 of public notary Novita Puspitarini, S.H. The Company started its commercial operations in 2016.
Read more on CASH →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →